ID   ORNT1_HUMAN             Reviewed;         301 AA.
AC   Q9Y619; Q5VZD8; Q9HC45;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   15-MAR-2017, entry version 151.
DE   RecName: Full=Mitochondrial ornithine transporter 1;
DE   AltName: Full=Solute carrier family 25 member 15;
GN   Name=SLC25A15; Synonyms=ORNT1; ORFNames=SP1855;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS HHH SYNDROME LYS-180 AND
RP   PHE-188 DEL.
RX   PubMed=10369256; DOI=10.1038/9658;
RA   Camacho J.A., Obie C., Biery B., Goodman B.K., Hu A., Almashanu S.,
RA   Steel G., Casey R., Lombard M., Mitchell G.A., Valle D.;
RT   "Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome is
RT   caused by mutations in a gene encoding a mitochondrial ornithine
RT   transporter.";
RL   Nat. Genet. 22:151-158(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND CHARACTERIZATION OF VARIANTS
RP   HHH SYNDROME ARG-27; PHE-188 DEL; ASP-190 AND GLN-275.
RX   PubMed=12807890; DOI=10.1074/jbc.M302317200;
RA   Fiermonte G., Dolce V., David L., Santorelli F.M., Dionisi-Vici C.,
RA   Palmieri F., Walker J.E.;
RT   "The mitochondrial ornithine transporter. Bacterial expression,
RT   reconstitution, functional characterization, and tissue distribution
RT   of two human isoforms.";
RL   J. Biol. Chem. 278:32778-32783(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [9]
RP   VARIANT HHH SYNDROME GLU-27.
RX   PubMed=10805333;
RX   DOI=10.1002/1531-8249(200005)47:5<625::AID-ANA10>3.3.CO;2-H;
RA   Tsujino S., Kanazawa N., Ohashi T., Eto Y., Saito T., Kira J.,
RA   Yamada T.;
RT   "Three novel mutations (G27E, insAAC, R179X) in the ORNT1 gene of
RT   Japanese patients with hyperornithinemia, hyperammonemia, and
RT   homocitrullinuria syndrome.";
RL   Ann. Neurol. 47:625-631(2000).
RN   [10]
RP   VARIANTS HHH SYNDROME ARG-27; PHE-188 DEL; ASP-190 AND GLN-275.
RX   PubMed=11668643; DOI=10.1002/humu.1221;
RA   Salvi S., Dionisi-Vici C., Bertini E., Verardo M., Santorelli F.M.;
RT   "Seven novel mutations in the ORNT1 gene (SLC25A15) in patients with
RT   hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome.";
RL   Hum. Mutat. 18:460-460(2001).
RN   [11]
RP   VARIANTS HHH SYNDROME ARG-27; PHE-188 DEL; ASP-190 AND GLN-275.
RX   PubMed=11552031; DOI=10.1212/WNL.57.5.911;
RA   Salvi S., Santorelli F.M., Bertini E., Boldrini R., Meli C.,
RA   Donati A., Burlina A.B., Rizzo C., Di Capua M., Fariello G.,
RA   Dionisi-Vici C.;
RT   "Clinical and molecular findings in hyperornithinemia-hyperammonemia-
RT   homocitrullinuria syndrome.";
RL   Neurology 57:911-914(2001).
RN   [12]
RP   VARIANT HHH SYNDROME ARG-126.
RX   PubMed=11814739; DOI=10.1016/S0887-8994(01)00335-6;
RA   Miyamoto T., Kanazawa N., Hayakawa C., Tsujino S.;
RT   "A novel mutation, P126R, in a Japanese patient with HHH syndrome.";
RL   Pediatr. Neurol. 26:65-67(2002).
RN   [13]
RP   VARIANTS HHH SYNDROME CYS-113 AND LYS-273.
RX   PubMed=16601889; DOI=10.1007/s10545-006-0120-7;
RA   Fecarotta S., Parenti G., Vajro P., Zuppaldi A., Della Casa R.,
RA   Carbone M.T., Correra A., Torre G., Riva S., Dionisi-Vici C.,
RA   Santorelli F.M., Andria G.;
RT   "HHH syndrome (hyperornithinaemia, hyperammonaemia,
RT   homocitrullinuria), with fulminant hepatitis-like presentation.";
RL   J. Inherit. Metab. Dis. 29:186-189(2006).
RN   [14]
RP   VARIANTS HHH SYNDROME ARG-27; ARG-37; LEU-70; GLN-71; LEU-188;
RP   SER-216; ILE-272 AND PHE-283, AND CHARACTERIZATION OF VARIANTS HHH
RP   SYNDROME ARG-37; GLN-71; CYS-113; ILE-272; LYS-273 AND PHE-283.
RX   PubMed=19242930; DOI=10.1002/humu.20930;
RA   Tessa A., Fiermonte G., Dionisi-Vici C., Paradies E.,
RA   Baumgartner M.R., Chien Y.-H., Loguercio C., de Baulny H.O.,
RA   Nassogne M.-C., Schiff M., Deodato F., Parenti G., Rutledge S.L.,
RA   Vilaseca M.A., Melone M.A.B., Scarano G., Aldamiz-Echevarria L.,
RA   Besley G., Walter J., Martinez-Hernandez E., Hernandez J.M.,
RA   Pierri C.L., Palmieri F., Santorelli F.M.;
RT   "Identification of novel mutations in the SLC25A15 gene in
RT   hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a
RT   clinical, molecular, and functional study.";
RL   Hum. Mutat. 30:741-748(2009).
CC   -!- FUNCTION: Ornithine transport across inner mitochondrial membrane,
CC       from the cytoplasm to the matrix.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass
CC       membrane protein.
CC   -!- DISEASE: Hyperornithinemia-hyperammonemia-homocitrullinuria
CC       syndrome (HHH syndrome) [MIM:238970]: Autosomal recessive disorder
CC       resulting in various neurologic symptoms, including mental
CC       retardation, spastic paraparesis with pyramidal signs, cerebellar
CC       ataxia, and episodic disturbance of consciousness or coma caused
CC       by hyperammonemia. It causes a functional impairment of the urea
CC       cycle. {ECO:0000269|PubMed:10369256, ECO:0000269|PubMed:10805333,
CC       ECO:0000269|PubMed:11552031, ECO:0000269|PubMed:11668643,
CC       ECO:0000269|PubMed:11814739, ECO:0000269|PubMed:16601889,
CC       ECO:0000269|PubMed:19242930}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF112968; AAD45238.1; -; mRNA.
DR   EMBL; AJ309943; CAC83972.1; -; Genomic_DNA.
DR   EMBL; AF177333; AAG17977.1; -; mRNA.
DR   EMBL; AL161614; CAH72774.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08630.1; -; Genomic_DNA.
DR   EMBL; BC002702; AAH02702.1; -; mRNA.
DR   CCDS; CCDS9373.1; -.
DR   RefSeq; NP_055067.1; NM_014252.3.
DR   UniGene; Hs.646645; -.
DR   ProteinModelPortal; Q9Y619; -.
DR   BioGrid; 115468; 14.
DR   STRING; 9606.ENSP00000342267; -.
DR   DrugBank; DB00129; L-Ornithine.
DR   TCDB; 2.A.29.19.2; the mitochondrial carrier (mc) family.
DR   iPTMnet; Q9Y619; -.
DR   PhosphoSitePlus; Q9Y619; -.
DR   BioMuta; SLC25A15; -.
DR   DMDM; 20139303; -.
DR   EPD; Q9Y619; -.
DR   MaxQB; Q9Y619; -.
DR   PaxDb; Q9Y619; -.
DR   PeptideAtlas; Q9Y619; -.
DR   PRIDE; Q9Y619; -.
DR   DNASU; 10166; -.
DR   Ensembl; ENST00000338625; ENSP00000342267; ENSG00000102743.
DR   GeneID; 10166; -.
DR   KEGG; hsa:10166; -.
DR   UCSC; uc001uxn.4; human.
DR   CTD; 10166; -.
DR   DisGeNET; 10166; -.
DR   GeneCards; SLC25A15; -.
DR   GeneReviews; SLC25A15; -.
DR   H-InvDB; HIX0011260; -.
DR   HGNC; HGNC:10985; SLC25A15.
DR   HPA; HPA042146; -.
DR   MalaCards; SLC25A15; -.
DR   MIM; 238970; phenotype.
DR   MIM; 603861; gene.
DR   neXtProt; NX_Q9Y619; -.
DR   OpenTargets; ENSG00000102743; -.
DR   Orphanet; 415; Hyperornithinemia-hyperammonemia-homocitrullinuria.
DR   PharmGKB; PA35861; -.
DR   eggNOG; KOG0763; Eukaryota.
DR   eggNOG; ENOG410XNVH; LUCA.
DR   GeneTree; ENSGT00730000110966; -.
DR   HOGENOM; HOG000168307; -.
DR   HOVERGEN; HBG062630; -.
DR   InParanoid; Q9Y619; -.
DR   KO; K15101; -.
DR   OMA; DMYKGIV; -.
DR   OrthoDB; EOG091G0HVE; -.
DR   PhylomeDB; Q9Y619; -.
DR   TreeFam; TF314880; -.
DR   Reactome; R-HSA-70635; Urea cycle.
DR   SABIO-RK; Q9Y619; -.
DR   ChiTaRS; SLC25A15; human.
DR   GenomeRNAi; 10166; -.
DR   PRO; PR:Q9Y619; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000102743; -.
DR   CleanEx; HS_SLC25A15; -.
DR   ExpressionAtlas; Q9Y619; baseline and differential.
DR   Genevisible; Q9Y619; HS.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0000064; F:L-ornithine transmembrane transporter activity; EXP:Reactome.
DR   GO; GO:0000066; P:mitochondrial ornithine transport; TAS:ProtInc.
DR   GO; GO:0000050; P:urea cycle; TAS:Reactome.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom.
DR   Pfam; PF00153; Mito_carr; 3.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Polymorphism; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    301       Mitochondrial ornithine transporter 1.
FT                                /FTId=PRO_0000090650.
FT   TRANSMEM      5     25       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    110    130       Helical; Name=3. {ECO:0000255}.
FT   TRANSMEM    168    188       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    207    227       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    237    257       Helical; Name=6. {ECO:0000255}.
FT   REPEAT        7     91       Solcar 1.
FT   REPEAT      104    197       Solcar 2.
FT   REPEAT      207    293       Solcar 3.
FT   VARIANT      27     27       G -> E (in HHH syndrome).
FT                                {ECO:0000269|PubMed:10805333}.
FT                                /FTId=VAR_012757.
FT   VARIANT      27     27       G -> R (in HHH syndrome; incapable of
FT                                catalyzing homo-exchanges of ornithine,
FT                                arginine, lysine and citrulline;
FT                                dbSNP:rs104894430).
FT                                {ECO:0000269|PubMed:11552031,
FT                                ECO:0000269|PubMed:11668643,
FT                                ECO:0000269|PubMed:12807890,
FT                                ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_012758.
FT   VARIANT      37     37       M -> R (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs121908533).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058948.
FT   VARIANT      70     70       A -> L (in HHH syndrome; requires 2
FT                                nucleotide substitutions; unknown
FT                                pathological significance).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058949.
FT   VARIANT      71     71       L -> Q (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs121908534).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058950.
FT   VARIANT     113    113       G -> C (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs199894905).
FT                                {ECO:0000269|PubMed:16601889,
FT                                ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058951.
FT   VARIANT     126    126       P -> R (in HHH syndrome).
FT                                {ECO:0000269|PubMed:11814739}.
FT                                /FTId=VAR_012759.
FT   VARIANT     180    180       E -> K (in HHH syndrome;
FT                                dbSNP:rs104894424).
FT                                {ECO:0000269|PubMed:10369256}.
FT                                /FTId=VAR_012760.
FT   VARIANT     188    188       F -> L (in HHH syndrome;
FT                                dbSNP:rs141028076).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058952.
FT   VARIANT     188    188       Missing (in HHH syndrome; maintains a
FT                                residual transport activity of 10%).
FT                                {ECO:0000269|PubMed:10369256,
FT                                ECO:0000269|PubMed:11552031,
FT                                ECO:0000269|PubMed:11668643,
FT                                ECO:0000269|PubMed:12807890}.
FT                                /FTId=VAR_012761.
FT   VARIANT     190    190       G -> D (in HHH syndrome; maintains a
FT                                residual transport activity of 35%;
FT                                dbSNP:rs202247804).
FT                                {ECO:0000269|PubMed:11552031,
FT                                ECO:0000269|PubMed:11668643,
FT                                ECO:0000269|PubMed:12807890}.
FT                                /FTId=VAR_012762.
FT   VARIANT     216    216       G -> S (in HHH syndrome).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058953.
FT   VARIANT     254    254       I -> L (in dbSNP:rs17849654).
FT                                /FTId=VAR_012763.
FT   VARIANT     272    272       T -> I (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs121908535).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058954.
FT   VARIANT     273    273       M -> K (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs202247808).
FT                                {ECO:0000269|PubMed:16601889,
FT                                ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058955.
FT   VARIANT     275    275       R -> Q (in HHH syndrome;
FT                                dbSNP:rs104894431).
FT                                {ECO:0000269|PubMed:11552031,
FT                                ECO:0000269|PubMed:11668643,
FT                                ECO:0000269|PubMed:12807890}.
FT                                /FTId=VAR_012764.
FT   VARIANT     283    283       L -> F (in HHH syndrome; exhibits very
FT                                low transport activity despite normal
FT                                insertion in the liposomal membrane;
FT                                dbSNP:rs202247809).
FT                                {ECO:0000269|PubMed:19242930}.
FT                                /FTId=VAR_058956.
SQ   SEQUENCE   301 AA;  32736 MW;  34436A15B105DC53 CRC64;
     MKSNPAIQAA IDLTAGAAGG TACVLTGQPF DTMKVKMQTF PDLYRGLTDC CLKTYSQVGF
     RGFYKGTSPA LIANIAENSV LFMCYGFCQQ VVRKVAGLDK QAKLSDLQNA AAGSFASAFA
     ALVLCPTELV KCRLQTMYEM ETSGKIAKSQ NTVWSVIKSI LRKDGPLGFY HGLSSTLLRE
     VPGYFFFFGG YELSRSFFAS GRSKDELGPV PLMLSGGVGG ICLWLAVYPV DCIKSRIQVL
     SMSGKQAGFI RTFINVVKNE GITALYSGLK PTMIRAFPAN GALFLAYEYS RKLMMNQLEA
     Y
//
